BTF acquired by bioMerieux
Australian company BTF Decisive Microbiology has been acquired by bioMerieux. French clinical diagnostics company bioMérieux is present in more than 150 countries through 35 subsidiaries and has a large network of distributors.
The new acquisition will make BTF's products more accessible to a wider distribution network.
Initially, BTF will operate as a standalone subsidiary, so all existing customers will not see any changes in the short term. BTF's contact details remain unchanged.
Jian Zhou Medal recognises anaesthesia, blood pressure research
The Australian Academy of Health and Medical Sciences has announced Professor Britta Regli-von...
Australian among 2025 Nobel Prize winners
The first of the 2025 Nobel Prizes have been announced — and this year's awards...
ATSE elects its next President, 2025 Fellows
The Australian Academy of Technological Sciences and Engineering (ATSE) has elected 35 new...
